日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/07/16 | 8,570 | 8,700 | 8,560 | 8,570 | -150 | -1.7% | 74,800 |
| 2021/07/15 | 8,860 | 8,900 | 8,700 | 8,720 | -40 | -0.5% | 101,200 |
| 2021/07/14 | 8,750 | 8,860 | 8,710 | 8,760 | -30 | -0.3% | 124,800 |
| 2021/07/13 | 8,840 | 8,930 | 8,740 | 8,790 | +20 | +0.2% | 97,400 |
| 2021/07/12 | 8,720 | 8,830 | 8,690 | 8,770 | +190 | +2.2% | 106,300 |
| 2021/07/09 | 8,450 | 8,610 | 8,410 | 8,580 | -20 | -0.2% | 182,500 |
| 2021/07/08 | 8,640 | 8,730 | 8,600 | 8,600 | -130 | -1.5% | 143,100 |
| 2021/07/07 | 8,650 | 8,780 | 8,600 | 8,730 | +70 | +0.8% | 130,400 |
| 2021/07/06 | 8,760 | 8,760 | 8,660 | 8,660 | -100 | -1.1% | 60,000 |
| 2021/07/05 | 8,800 | 8,900 | 8,760 | 8,760 | +10 | +0.1% | 90,600 |
| 2021/07/02 | 8,780 | 8,930 | 8,730 | 8,750 | -30 | -0.3% | 202,400 |
| 2021/07/01 | 8,800 | 8,800 | 8,670 | 8,780 | -30 | -0.3% | 162,900 |
| 2021/06/30 | 9,110 | 9,120 | 8,780 | 8,810 | -270 | -3% | 206,400 |
| 2021/06/29 | 9,050 | 9,120 | 8,950 | 9,080 | ±0 | ±0% | 112,300 |
| 2021/06/28 | 9,170 | 9,170 | 8,980 | 9,080 | -20 | -0.2% | 192,900 |
| 2021/06/25 | 9,240 | 9,270 | 9,090 | 9,100 | -140 | -1.5% | 215,500 |
| 2021/06/24 | 9,300 | 9,360 | 9,190 | 9,240 | +240 | +2.7% | 201,700 |
| 2021/06/23 | 9,120 | 9,140 | 8,990 | 9,000 | -160 | -1.7% | 163,400 |
| 2021/06/22 | 9,000 | 9,160 | 8,880 | 9,160 | +180 | +2% | 216,300 |
| 2021/06/21 | 8,870 | 8,990 | 8,840 | 8,980 | +50 | +0.6% | 146,300 |
| 2021/06/18 | 8,920 | 8,950 | 8,840 | 8,930 | +80 | +0.9% | 250,300 |
| 2021/06/17 | 8,860 | 8,950 | 8,790 | 8,850 | -40 | -0.4% | 155,000 |
| 2021/06/16 | 8,750 | 8,930 | 8,690 | 8,890 | +240 | +2.8% | 173,500 |
| 2021/06/15 | 8,620 | 8,720 | 8,580 | 8,650 | -20 | -0.2% | 149,300 |
| 2021/06/14 | 8,750 | 8,770 | 8,630 | 8,670 | +150 | +1.8% | 145,800 |
| 2021/06/11 | 8,540 | 8,580 | 8,450 | 8,520 | +40 | +0.5% | 240,000 |
| 2021/06/10 | 8,420 | 8,510 | 8,390 | 8,480 | +110 | +1.3% | 144,800 |
| 2021/06/09 | 8,280 | 8,430 | 8,220 | 8,370 | +50 | +0.6% | 166,700 |
| 2021/06/08 | 8,280 | 8,380 | 8,240 | 8,320 | +190 | +2.3% | 203,500 |
| 2021/06/07 | 8,020 | 8,150 | 7,920 | 8,130 | +190 | +2.4% | 135,400 |
| 2021/06/04 | 7,790 | 7,950 | 7,710 | 7,940 | +130 | +1.7% | 157,800 |
| 2021/06/03 | 7,850 | 7,930 | 7,770 | 7,810 | -10 | -0.1% | 106,700 |
| 2021/06/02 | 7,780 | 7,840 | 7,670 | 7,820 | +30 | +0.4% | 150,600 |
| 2021/06/01 | 7,840 | 7,840 | 7,660 | 7,790 | -50 | -0.6% | 161,900 |
| 2021/05/31 | 7,880 | 7,960 | 7,770 | 7,840 | -90 | -1.1% | 165,000 |
| 2021/05/28 | 7,810 | 7,970 | 7,720 | 7,930 | +80 | +1% | 317,600 |
| 2021/05/27 | 7,700 | 7,920 | 7,640 | 7,850 | ±0 | ±0% | 664,700 |
| 2021/05/26 | 7,820 | 7,920 | 7,790 | 7,850 | +20 | +0.3% | 192,500 |
| 2021/05/25 | 8,000 | 8,010 | 7,810 | 7,830 | +50 | +0.6% | 203,100 |
| 2021/05/24 | 7,740 | 7,840 | 7,720 | 7,780 | +30 | +0.4% | 119,800 |
| 2021/05/21 | 7,590 | 7,780 | 7,530 | 7,750 | +80 | +1% | 158,700 |
| 2021/05/20 | 7,650 | 7,790 | 7,620 | 7,670 | +40 | +0.5% | 249,800 |
| 2021/05/19 | 7,310 | 7,680 | 7,270 | 7,630 | +400 | +5.5% | 363,500 |
| 2021/05/18 | 7,230 | 7,280 | 7,180 | 7,230 | +70 | +1% | 162,000 |
| 2021/05/17 | 7,000 | 7,340 | 6,930 | 7,160 | +10 | +0.1% | 295,400 |
| 2021/05/14 | 7,060 | 7,210 | 7,030 | 7,150 | +70 | +1% | 153,100 |
| 2021/05/13 | 7,110 | 7,180 | 7,000 | 7,080 | -40 | -0.6% | 176,000 |
| 2021/05/12 | 7,210 | 7,320 | 7,070 | 7,120 | -10 | -0.1% | 178,000 |
| 2021/05/11 | 7,300 | 7,360 | 7,130 | 7,130 | -280 | -3.8% | 189,600 |
| 2021/05/10 | 7,300 | 7,420 | 7,270 | 7,410 | +150 | +2.1% | 115,200 |
951～
1000
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
